Asthma and other allergic conditions in Colombia: a study in 6 cities

Rodolfo Dennis1, Luis Caraballo, Elizabeth García

  • 1Clinical Epidemiology and Biostatistics Unit, Pontificia Universidad Javeriana, Bogotá, Colombia.

Insights

Allergic diseases like asthma and rhinitis are prevalent in Colombian children and adults, causing significant lost school and workdays. This study highlights the substantial burden of these conditions in urban Colombia.

Area of Science:

  • Epidemiology
  • Public Health
  • Immunology

Background:

  • Limited data exists on the prevalence and impact of allergic diseases in Colombia and Latin America.
  • Allergic diseases affect both children and adults, necessitating a comprehensive understanding of their burden.

Purpose of the Study:

  • To determine the prevalence of asthma, allergic rhinitis, and atopic dermatitis symptoms in six Colombian cities.
  • To assess patient costs, school and workdays lost, and disease severity.
  • To measure total and specific IgE levels in subjects with asthma.

Main Methods:

  • A multistage stratified random sampling method was employed, including children aged 5-18, and adults and younger children through systematic sampling.
  • Home visits were conducted for data collection.
  • Blood samples were collected from subjects experiencing asthma symptoms.

Main Results:

  • The study surveyed 6,507 individuals.
  • Past 12-month prevalence was 10.4% for asthma, 22.6% for rhinitis, and 3.9% for atopic dermatitis.
  • Asthma was associated with emergency visits/hospitalization (38%), lost school/workdays (50%), and high atopy rates (76%).

Conclusions:

  • Allergic diseases represent a significant public health concern in urban Colombia.
  • The societal impact, including economic costs and lost productivity, is substantial.
  • These findings challenge the misconception that allergic diseases are solely a concern for industrialized nations.
Abstract

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...